| Application no. and date | 99916941.0 (espacenet) (Federated) (European Patent Register), 19990423 | | Patent/reg. no. and date | DK/EP 1071397, 20040128 | | Publication date | 20010131 | | Priority no. and date | FI 980901, 19980423 | | EP pub. no. and date |
EP 1071397 20010131 | | Effective date | | | Applicant/owner | Orion Corporation, Orionintie 1
02200 Espoo, FI | | Applicant ref. no. | 108475 | | Inventor | ANTILA, Saila, Kauppalantie 31 A 13
FIN-00320 Helsinki, FI,
LARMA, Ilkka, 51A Forest Drive, Springfield
New Jersey 07081, US,
LEHTONEN, Lasse, Kiitokalliontie 6B
02180 Espoo, FI,
BÄCKMAN, Maarit, Lehtisaarentie 6 B
FIN-00340 Helsinki, FI | | Representative | AWA Denmark A/S, Strandgade 56, 1401 København K, DK | | Opponent | | | IPC Class | A61K 31/50, A61K 9/00 | | Title | Levosimendan-holdige lægemidler til oral indgivelse med kontrolleret frisætning af det aktive middel | | Int. application no. | FI1999000329 | | Int. publication no. | WO1999055305 | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
